Prostate Cancer News on BioPortfolio

Effect of PectaSolCÂ modified citrus pectin PMCP treatment tx on PSA dynamics in patients pts with nonmetastatic biochemically relapsed prostate cancer BRPC Results of the interim analysis of a prospective phase II study

SANTA ROSA Calif. June 15 2017 PRNewswire Interim results from Phase IIb clinical trial showed impressive and promising results in patients with recurrent prostate cancer. The interim results have just been published in the Journal of Clinical Oncology in...

Researchers develop new test to target prostate cancer treatment

UKbased scientists have developed a new threeinone blood test able to identify the patients with advanced prostate cancer most likely to benefit from PARP inhibitors with the potential to ‘transform’ treatment of the disease.

Liquid Biopsy Guides New Prostate Cancer Drug Trial

Its been no secret that screening methods to detect prostate cancer have been woefully lacking and largely inconsistent with respect to the results they provide. Yet with the rise in validated biomarkers and advanced diagnostics coupled with nextgeneration...

Pages